Effects of Telmisartan on Ischemic Cardiovascular Events in High-risk Hypertensive Patients
Status:
Terminated
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
This study is aimed to investigate whether treatment with Telmisartan is more effective than
Candesartan in reducing the ischemic cardiovascular events in high-risk patients with
cardiovascular disease.